Scouring Genetic Variation within Our Cells for Drug Targets

Jacob Rubens, president of Quotient Therapeutics, discusses the company’s platform technology, how it uncovers genetic mutations at a cellular level, and its efforts to build a pipeline of therapies around the insights it gains.

Om Podcasten

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.